The Enterprise Value as of November 2024 (TTM) for Oramed Pharmaceuticals Inc. (ORMP) is 167.97M

According to Oramed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 167.97M. This represents a change of -16.81% compared to the average of 201.91M of the last 4 quarters.

Oramed Pharmaceuticals Inc. (ORMP) Historical Enterprise Value (quarterly & annually)

How has ORMP Enterprise Value performed in the past?

The mean historical Enterprise Value of Oramed Pharmaceuticals Inc. over the last ten years is 148.70M. The current 167.97M Enterprise Value has changed 11.20% with respect to the historical average. Over the past ten years (40 quarters), ORMP's Enterprise Value was at its highest in in the November 2021 quarter at 673.47M. The Enterprise Value was at its lowest in in the February 2015 quarter at 47.83M.

Oramed Pharmaceuticals Inc. (ORMP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oramed Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oramed Pharmaceuticals Inc. (ORMP) Average Enterprise Value

How has ORMP Enterprise Value performed in the past?

The current Enterprise Value of Oramed Pharmaceuticals Inc. (ORMP) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Oramed Pharmaceuticals Inc. (ORMP) Enterprise Value vs. Peers

How is ORMP’s Enterprise Value compared to its peers?

Oramed Pharmaceuticals Inc.’s Enterprise Value is greater than Protalix BioTherapeutics, Inc. (96.89M), less than Corvus Pharmaceuticals, Inc. (550.07M), less than Aldeyra Therapeutics, Inc. (292.41M), greater than Gamida Cell Ltd. (57.65M), greater than Checkpoint Therapeutics, Inc. (149.72M), greater than BioLineRx Ltd. (59.04M), less than Ardelyx, Inc. (1.45B), less than Lexicon Pharmaceuticals, Inc. (505.66M), less than Seres Therapeutics, Inc. (278.81M), less than ImmunityBio, Inc. (4.49B), greater than X4 Pharmaceuticals, Inc. (20.60M), less than Mereo BioPharma Group plc (535.33M), less than Inozyme Pharma, Inc. (308.76M), less than Terns Pharmaceuticals, Inc. (508.25M), greater than Leap Therapeutics, Inc. (62.43M), greater than Zura Bio Limited (90.25M), greater than Altamira Therapeutics Ltd. (1.17M), greater than Immix Biopharma, Inc. (20.49M), greater than Enveric Biosciences, Inc. (636.29K), greater than Palisade Bio, Inc. (-7153934.00), greater than Hepion Pharmaceuticals, Inc. (1.72M), greater than AVROBIO, Inc. (-85302404.00), greater than CohBar, Inc. (-4506335.00), greater than Ocean Biomedical, Inc. (42.20M), greater than Elevation Oncology, Inc. (2.36M),

Build a custom stock screener for Oramed Pharmaceuticals Inc. (ORMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oramed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oramed Pharmaceuticals Inc. (ORMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oramed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.